News

BioWorld: Fluorination Propels SciFluor into 'Billion-Dollar' Markets

26-Oct-2012

Fluorination Propels SciFluor Into ‘Billion-Dollar’ Markets 
By Marie Powers Staff Writer 

Nearly one in four marketed drugs contains the chemical element fluorine, including household names for vastly different indications such as Lipitor (atorvastatin, Pfizer Inc.), Cipro (ciprofloxacin, Bayer AG) and Prozac (fluoxetine, Eli Lilly and Co.) The reason? The carbon-fluorine bond, the strongest in organic chemistry, is widely used to block sites of metabolism and improve drug half-life. Using fluorine to modify the chemical structure of a drug has been demonstrated to improve potency, selectivity, tissue penetration, half-life and metabolic stability.

To read further please visit via subscription:

 

The Latest Press

27-Apr-2016

Ridge Global and OptioLabs Partner to Offer Effective Cybersecurity Products and Solutions

Ridge Global and OptioLabs Partner to Offer Effective Cybersecurity Products and Solutions Tom Ridge, First U.S. Secretary of Homeland Security and Fo..

26-Apr-2016

Allied Minds announces funding commitments of up to $80 million

Allied Minds announces funding commitments of up to $80 million for the development of up to 10 drug discovery programmes • Formation of new subsidi..

14-Apr-2016

HawkEye 360 Expands Management Team to Accelerate Commercial Development

HawkEye 360 Expands Management Team to Accelerate Commercial Development of Space-Based Radio Frequency Mapping and Analytics Technology • Joining Hawk..


Privacy Policy Terms of Use